Michael Lowe

16PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 14, 2025
Combination radiation and αPD-L1 enhance tumor control by stimulating CD8+ PD-1+ TCF-1+ T cells in the tumor-draining lymph node.

Yang Shen, Erin Connolly, Meili Aiello

|Mar 11, 2025
The Landmark Series: Melanoma and Adjuvant Therapy.

Michael C Lowe, Keith A Delman, David W Ollila

|Mar 26, 2024
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.

Jimmy S Patel, Yena Woo, Amber Draper

|Mar 18, 2024
Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.

Yang Shen, Erin Connolly, Meili Aiello

|Aug 23, 2023
FcγRIIB expressed on CD8+ T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.

Kelsey B Bennion, Marvi Tariq, Megan M Wyatt

|Mar 01, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

Sapna P Patel, Megan Othus, Yuanbin Chen

Pageof 3

Frequent Collaborators

3 joint publications

Edmund K Bartlett

3 joint publications

Haydn Kissick

3 joint publications

Chrystal M Paulos

2 joint publications

Sarwish Rafiq